Quantcast

Latest ThromboGenics NV Stories

2014-03-10 04:21:04

LEUVEN, Belgium, March 10, 2014 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR), an integrated biopharmaceutical company focused on developing and commercializing

2014-03-04 04:21:12

LEUVEN, Belgium, March 4, 2014 /PRNewswire/ -- Ocriplasmin Research to Better Inform Treatment (ORBIT) study designed to generate further

2014-02-24 04:21:43

LEUVEN, Belgium, February 24, 2014 /PRNewswire/ -- Focus on Realizing the Commercial Potential of JETREA(R)in the US and Capitalizing on the


Word of the Day
whirret
  • To give a box on the ear to.
The word 'whirret' may be onomatopoeic.